# Spark BioPharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/spark-biopharma

- Industry: Pharmaceuticals
- Headquarters: Seoul, South Korea
- Website: www.sparkbio.kr
- Total disclosed funding: $45M
- Latest round: Series C (Apr 1, 2022)
- Investors on record: 13

## About

Founded in 2016 and based in Seoul, South Korea, Spark BioPharma, Inc. develops a technology platform for drug screening and target identification for anti-cancer drug candidates. In April 2022, Spark BioPharma, Inc. raised KRW 25 billion in series C funding from returning investors Company K Partners, IMM Investment, KB Investment, and KTB Network, and new investors DT&Investment, Kiwoom Investment, Medytox Venture Investment, Shinhan Venture Investment, Time Folio Asset Management, and We Venture Partners.

The April investment will help Spark BioPharma, Inc. with its domestic and overseas clinical trials and develop technology exported to global pharmaceutical companies.

## Funding rounds

- Series C, Apr 1, 2022, $18M — Shinhan Venture Investment, KB Investment, WOORI Venture Partners, Industrial Bank of Korea, IMM Investment, Company K Partners, Kiwoom Investment, DT&Investment, We Venture Partners, Medytox Venture Investment
- Series B, Aug 23, 2019, $21M — KB Investment, WOORI Venture Partners, Partners Investment, IMM Investment, Company K Partners, E & Venture Partners
- Series A, Jun 30, 2018, $4M — KB Investment, Solidus Investment
- Seed, Sep 10, 2016, $2.7M — KB Investment, Solidus Investment

## Investors

- KB Investment (https://capitalatlas.ai/funds/kb-investment) — Seed, Series A, Series B, Series C
- Solidus Investment (https://capitalatlas.ai/funds/solidus-investment) — Seed, Series A
- WOORI Venture Partners (https://capitalatlas.ai/funds/woori-venture-partners) — Series B, Series C
- Partners Investment (https://capitalatlas.ai/funds/partners-investment) — Series B
- IMM Investment (https://capitalatlas.ai/funds/imm-investment) — Series B, Series C
- Company K Partners (https://capitalatlas.ai/funds/company-k-partners) — Series B, Series C
- E & Venture Partners (https://capitalatlas.ai/funds/e-venture-partners-2) — Series B
- Shinhan Venture Investment (https://capitalatlas.ai/funds/shinhan-venture-investment) — Series C
- Industrial Bank of Korea — Series C
- Kiwoom Investment (https://capitalatlas.ai/funds/kiwoom-investment) — Series C
- DT&Investment (https://capitalatlas.ai/funds/dt-investment) — Series C
- We Venture Partners (https://capitalatlas.ai/funds/we-venture-partners) — Series C
- Medytox Venture Investment (https://capitalatlas.ai/funds/medytox-venture-investment) — Series C